See how smarter filling saved a biologic from a double-digit reject rate. A small amount of liquid left on the vial wall can mean a costly reject, especially when a high-value API is on the line. For one client's high-value biologic, that meant reject rates reaching...
Find out how engineering-led cycle development bridged the gap from benchtop to validated-scale up. What works on a benchtop doesn't always survive the jump to a large-scale lyophilizer. See how JHS engineers identified the root cause of a failed PPQ validation run...
Challenge An existing partner wanted to work with JHS toinvestigate new ways to reduce the cycle time of abiologic product in order to serve more patients. Approach JHS has worked with this top 20 global pharmapartner for 15+ years on this drug product andsearched for...